Clinical Trials Browser

NIH × Breast Neoplasms × Bortezomib × Clear all

NCT01142401 2023-11-27

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Phase 2 Completed

118 enrolled 11 charts

Breast Neoplasms

NCT00025584 2013-01-23

PS-341 in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms